Brian K. Halak, Director at Dicerna Pharmaceuticals Inc (DRNA), sold 666,032 shares at $13.47 ($8.9M) on 2018-11-02, disclosed to the SEC on 2018-11-06.
Open-market sale of $8.9M DRNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.47 | 189,359 | $2.6M | 28.7% |
| 2 | $13.47 | 189,359 | $2.6M | 28.7% |
| 3 | $13.47 | 1,412 | $19K | 0.2% |
| 4 | $12.98 | 39,606 | $514K | 5.8% |
| 5 | $12.98 | 295 | $4K | 0.0% |
| 6 | $12.98 | 39,606 |
| $514K |
| 5.8% |
| 7 | $13.18 | 761 | $10K | 0.1% |
| 8 | $13.18 | 102,067 | $1.3M | 15.2% |
| 9 | $13.18 | 102,067 | $1.3M | 15.2% |
| 10 | $14.16 | 11 | $156 | 0.0% |
| 11 | $14.16 | 1,489 | $21K | 0.2% |
| Total | $13.32 avg | 666,032 | $8.9M | 100% |
| Filing → |
| EVOK | SELL | 2015-08-20 | $1K | — | Filing → |
| ESPR | BUY | 2014-10-21 | $10.0M | — | Filing → |
| ATRA | BUY | 2014-10-21 | $20K | — | Filing → |